PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1372033
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1372033
DNA Sequencing Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Services), Technology (Next-Generation, Sequencing, Third Generation DNA Sequencing and Other Technologies), Application, End User and By Geography
According to Stratistics MRC, the Global DNA Sequencing Market is accounted for $12.5 billion in 2023 and is expected to reach $42.5 billion by 2030 growing at a CAGR of 19.1% during the forecast period. DNA sequencing is a procedure that uses extensive parallelization to sequence different DNA strands. The advantages of DNA sequencing over microarray and other genetic analysis techniques include cheaper cost, higher accuracy and speed, and reliable results even with small sample input, applications for DNA sequencing include the identification of biomarkers, oncology research, individualized healthcare, forensics, and others.
According to National Human Genome Research Institute, due to continuous innovations, the cost of NGS per genome is USD 562, and the cost of NGS per megabase is USD 0.006 in August 2021.
Market Dynamics:
Driver:
Rising demand in genome sequencing
Genome sequencing is in greater demand in the DNA sequencing industry due to its transformational effects across a number of fields. Additionally, a rise in clinical applications is being caused by the necessity of genome sequencing in genetic diagnostics, customized medicine, and cancer research. Furthermore, the need for genome sequencing is anticipated to increase as genomics continues to shed light on the mechanisms underlying disease and potential treatments. Thus, this will encourage new product development and market expansion for DNA sequencing.
Restraint:
High cost
The high cost of DNA sequencing technologies is a key market obstacle. Equipment, consumables, and data processing are included in these costs, which frequently make sequencing efforts financially burdensome. Additionally, sequencing programs require huge amounts of cash from research institutions, clinical laboratories, and healthcare facilities, particularly in environments with limited resources, high expenses can restrict access to cutting-edge sequencing techniques and deter widespread adoption. Therefore, hampers the market expansion.
Opportunity:
Technological Advancements in DNA Sequencing
Genomic research and clinical applications have undergone a revolution due to technological developments in DNA sequencing. Additionally, high-throughput sequencing is made possible by next-generation sequencing (NGS) technologies from companies like Illumina and Oxford Nanopore. Moreover, because of the developments, large-scale genomic studies it has become more affordable, and data gathering has been speed up. The accuracy of DNA sequencing has increased because of single-molecule sequencing and long-read technologies, which also make it easier to analyze complex genomic areas. Furthermore, this has increased the accessibility and effect of genomics by enabling researchers and clinicians to conduct sequencing activities in a variety of contexts, from rural locations to clinical facilities. Therefore, these factors significantly have driven the market expansion.
Threat:
Risks associated with privacy and data analysis
The market for DNA sequencing has been hampered by privacy issues, as the use of genetic testing increases, people and organizations express concern about the security and potential abuse of highly sensitive genetic data. Additionally, this has made people hesitant to take part in genetic research and share information with healthcare professionals, which has slowed the development of genomics research and therapeutic applications. Furthermore, modern sequencing technologies create enormous amounts of data, which poses substantial computing and data analytic obstacles and hampers effective interpretation and utilization.
COVID-19 Impact
The market for DNA sequencing was negatively impacted by the COVID-19 epidemic. The pandemic impacted sequencing initiatives and research funding for non-pandemic projects by disrupting the supply chain, limiting laboratory access, and creating financial restrictions in healthcare institutions. Despite these challenges, the pandemic accelerated the adoption of sequencing for the research of infectious diseases, which gradually restrained market expansion.
The consumables segment is expected to be the largest during the forecast period
The consumables segment is estimated to hold the largest share, due to the widespread availability of reagents and kits for all library construction phases, including DNA fragmentation, enrichment, adapter ligation, amplification, and quality control. Additionally, this includes consumables used for sample preparation and analysis, flow cells, primers, buffers, and sequencing reagents. Consumables are essential to the sequencing workflow because they guarantee the precision and effectiveness of DNA sequencing. Therefore, the consumables industry provides manufacturers with a crucial and consistent source of income and is essential to the advancement of genomics research, clinical diagnostics, and customized medicine.
The next-generation sequencing segment is expected to have the highest CAGR during the forecast period
The next-generation sequencing segment is anticipated to have lucrative growth during the forecast period, due to its capacity to produce high-quality sequence data at affordable prices, NGS has become the predominant sequencing methodology. Furthermore, NGS has been shown to be more accurate than conventional sequencing techniques, making it appropriate for uses like cancer detection and genomics research. Moreover, massively parallel sequencers called next-generation sequencing (NGS) systems can produce a lot of data in a short amount of time. Therefore, due to its excellent accuracy and detection capacities, next-generation sequencing technology is anticipated to gain a greater market share.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period due to the active participation of the region's economies. Additionally, many nations in the region have started large-scale genomics initiatives and research plans. Examples of significant initiatives encouraging genomics applications in healthcare include Japan's "Japanese Genomic Medicine Program" and China's "Precision Medicine Initiative". Furthermore, governmental funding and partnerships with business titans are also encouraging innovation in the sector. The enormous population of the Asia-Pacific area creates a sizable market for genetic testing and tailored medicine. Thus, as a result, the area is gradually becoming a focus for genomics research and the expansion of the DNA sequencing sector.
Region with highest CAGR:
Europe is expected to witness highest CAGR over the projection period. The area benefits from a vibrant scientific community, esteemed research institutions, and a friendly regulatory environment that promotes creativity and financial investment in genomics research. Additionally, the demand for genomic applications in personalized medicine, genetic diagnostics, and pharmacogenomics has increased as a result of significant investments made in healthcare in European nations. Furthermore, large-scale genomics initiatives are encouraged by international cooperation, which raises the region's competitiveness. Therefore, the universal healthcare systems in Europe make it easier to incorporate genomic data into clinical practice, which stimulates market expansion.
Key players in the market:
Some of the key players in the DNA Sequencing Market include: Agilent Technologies Inc., Pacific Biosciences of California Inc., Hamilton Thorne Biosciences, Bio-Rad Laboratories Inc., Danaher Corporation, Hoffmann-La Roche Ltd, Illumina Inc., Merck KGaA, Qiagen, PerkinElmer Inc., Macrogen Inc., Myriad Genetics Inc. and Eurofins Scientific.
Key Developments:
In March 2023, llumina Inc. a global leader in DNA sequencing and array-based technologies, announced that its first product based on its novel Illumina Complete Long Read technology is now available to order.
In September 2022, Illumina, Inc. announced the launch of the NovaSeq™ X Series (NovaSeq X and NovaSeq X Plus), new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing.
In January 2019, NRGene and Macrogen Corp announced the launch of a joint sequencing-based genotyping service, ArrayMAGIC, at the Plant and Animal Genome (PAG) conference in San Diego.
Products Covered:
- Consumables
- Instruments
- Services
Technologies Covered:
- Next-Generation Sequencing
- Third Generation DNA Sequencing
- Other Technologies
Applications Covered:
- Oncology
- Clinical Investigation
- Forensics & Agrigenomics
- Human Leukocyte Antigen (HLA) Typing
- Reproductive Health
- Other Applications
End Users Covered:
- Academic Research
- Clinical Research
- Biotechnology & Pharmaceutical Companies
- Hospitals & Clinics
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Technology Analysis
- 3.8 Application Analysis
- 3.9 End User Analysis
- 3.10 Emerging Markets
- 3.11 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global DNA Sequencing Market, By Product
- 5.1 Introduction
- 5.2 Consumables
- 5.3 Instruments
- 5.4 Services
6 Global DNA Sequencing Market, By Technology
- 6.1 Introduction
- 6.2 Next-Generation Sequencing
- 6.3 Third Generation DNA Sequencing
- 6.4 Other Technologies
7 Global DNA Sequencing Market, By Application
- 7.1 Introduction
- 7.2 Oncology
- 7.3 Clinical Investigation
- 7.4 Forensics & Agrigenomics
- 7.5 Human Leukocyte Antigen (HLA) Typing
- 7.6 Reproductive Health
- 7.7 Other Applications
8 Global DNA Sequencing Market, By End Use
- 8.1 Introduction
- 8.2 Academic Research
- 8.3 Clinical Research
- 8.4 Biotechnology & Pharmaceutical Companies
- 8.5 Hospitals & Clinics
- 8.6 Other End Users
9 Global DNA Sequencing Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Agilent Technologies Inc.
- 11.2 Pacific Biosciences of California Inc.
- 11.3 Hamilton Thorne Biosciences
- 11.4 Bio-Rad Laboratories Inc.
- 11.5 Danaher Corporation
- 11.6 Hoffmann-La Roche Ltd
- 11.7 Illumina Inc.
- 11.8 Merck KGaA
- 11.9 Qiagen
- 11.10 PerkinElmer Inc.
- 11.11 Macrogen Inc.
- 11.12 Myriad Genetics Inc.
- 11.13 Eurofins Scientific
List of Tables
- Table 1 Global DNA Sequencing Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
- Table 4 Global DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
- Table 5 Global DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
- Table 6 Global DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
- Table 7 Global DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
- Table 8 Global DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
- Table 9 Global DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 10 Global DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
- Table 11 Global DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
- Table 12 Global DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
- Table 13 Global DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
- Table 14 Global DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
- Table 15 Global DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
- Table 16 Global DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 17 Global DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
- Table 18 Global DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
- Table 19 Global DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
- Table 20 Global DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
- Table 21 Global DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 22 Global DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 23 North America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
- Table 24 North America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
- Table 25 North America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
- Table 26 North America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
- Table 27 North America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
- Table 28 North America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
- Table 29 North America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
- Table 30 North America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
- Table 31 North America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 32 North America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
- Table 33 North America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
- Table 34 North America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
- Table 35 North America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
- Table 36 North America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
- Table 37 North America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
- Table 38 North America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 39 North America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
- Table 40 North America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
- Table 41 North America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
- Table 42 North America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
- Table 43 North America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 44 North America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 45 Europe DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
- Table 46 Europe DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
- Table 47 Europe DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
- Table 48 Europe DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
- Table 49 Europe DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
- Table 50 Europe DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
- Table 51 Europe DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
- Table 52 Europe DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
- Table 53 Europe DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 54 Europe DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
- Table 55 Europe DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
- Table 56 Europe DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
- Table 57 Europe DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
- Table 58 Europe DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
- Table 59 Europe DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
- Table 60 Europe DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 61 Europe DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
- Table 62 Europe DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
- Table 63 Europe DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
- Table 64 Europe DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
- Table 65 Europe DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 66 Europe DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 67 South America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
- Table 68 South America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
- Table 69 South America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
- Table 70 South America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
- Table 71 South America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
- Table 72 South America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
- Table 73 South America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
- Table 74 South America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
- Table 75 South America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 76 South America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
- Table 77 South America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
- Table 78 South America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
- Table 79 South America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
- Table 80 South America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
- Table 81 South America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
- Table 82 South America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 83 South America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
- Table 84 South America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
- Table 85 South America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
- Table 86 South America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
- Table 87 South America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 88 South America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 89 Middle East & Africa DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
- Table 90 Middle East & Africa DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
- Table 91 Middle East & Africa DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
- Table 92 Middle East & Africa DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
- Table 93 Middle East & Africa DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
- Table 94 Middle East & Africa DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
- Table 95 Middle East & Africa DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
- Table 96 Middle East & Africa DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
- Table 97 Middle East & Africa DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 98 Middle East & Africa DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
- Table 99 Middle East & Africa DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
- Table 100 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
- Table 101 Middle East & Africa DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
- Table 102 Middle East & Africa DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
- Table 103 Middle East & Africa DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
- Table 104 Middle East & Africa DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 105 Middle East & Africa DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
- Table 106 Middle East & Africa DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
- Table 107 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
- Table 108 Middle East & Africa DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
- Table 109 Middle East & Africa DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 110 Middle East & Africa DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
